С. В. Недогода
-
- Blood Pressure and Hypertension Studies 36
- Cardiovascular Health and Disease Prevention 12
- Cardiovascular Function and Risk Factors 9
- Heart Rate Variability and Autonomic Control 9
- Nephrology top 10%
- Geriatrics and Gerontology top 10%
-
- Hormonal Regulation and Hypertension 12
- Diabetes Treatment and Management 10
-
- Healthcare Systems and Public Health 11
-
- Neurological Disorders and Treatments 9
- Co-authors
- A. S. SalasyukVesna StojanovА. О. КонрадиВ. В. ЦомаA. A. LedyaevaЕ. V. ShlyakhtoYu. V. ZhernakovaЕ. И. Баранова
- Partner nations
- RussiaUnited StatesCroatia
In The Last Decade
С. В. Недогода
73 papers receiving 503 citations
Peers
Comparison fields: 5 of 81
- Applied Microbiology and Biotechnology 59
- Cardiology and Cardiovascular Medicine 275
- Nephrology 62
- Family Practice 17
- Geriatrics and Gerontology 27
Countries citing papers authored by С. В. Недогода
This map shows the geographic impact of С. В. Недогода's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by С. В. Недогода with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites С. В. Недогода more than expected).
Fields of papers citing papers by С. В. Недогода
This network shows the impact of papers produced by С. В. Недогода. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by С. В. Недогода. The network helps show where С. В. Недогода may publish in the future.
Co-authorship network
The 25 scholars most cited alongside С. В. Недогода, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 2 | |
| 14 | 2020 | 3 | |
| 15 | Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus: the role of PCSK9 inhibitors | 2018 | 1 |
| 16 | 2018 | 27 | |
| 17 | 2017 | 7 | |
| 18 | 2014 | 1 | |
| 19 | MILDRONATE POTENTIAL FOR CORRECTING COGNITIVE DYSFUNCTION IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION | 2011 | 1 |
| 20 | [Treatment of irritable bowel syndrome with dicetelium and spasmomen]. | 2000 | 4 |
About С. В. Недогода
С. В. Недогода is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Anatomy, having authored 94 papers that have together received 585 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (36 papers), Hormonal Regulation and Hypertension (12 papers), Cardiovascular Health and Disease Prevention (12 papers), Healthcare Systems and Public Health (11 papers), Diabetes Treatment and Management (10 papers), Cardiovascular Function and Risk Factors (9 papers), Neurological Disorders and Treatments (9 papers) and Heart Rate Variability and Autonomic Control (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (59 citations), Cardiology and Cardiovascular Medicine (275 citations) and Nephrology (62 citations). С. В. Недогода has collaborated with scholars based in Russia, United States and Croatia. Frequent co-authors include A. S. Salasyuk, Vesna Stojanov, А. О. Конради, В. В. Цома, A. A. Ledyaeva, Е. V. Shlyakhto, Yu. V. Zhernakova, Е. И. Баранова, Р. А. Либис and Г. А. Чумакова. Their work appears in journals such as Journal of Hypertension, Clinical Infectious Diseases, Diabetes, Cardiology and Therapy and American Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.